Atara Biotherapeutics, Inc.

Direct answer

Atara Biotherapeutics, Inc. is publicly traded on NASDAQ under the ticker ATRA.

Founded in 2012 and headquartered in South San Francisco, California, Atara Biotherapeutics, Inc. is dedicated to pioneering ready-to-use (off-the-shelf) T-cell immunotherapies. Their primary focus in the United States involves creating treatments for patients battling cancer, autoimmune disorders, and viral infections. A key therapeutic candidate, tabelecleucel, is currently undergoing Phase 3 clinical trials for...

Can you invest in Atara Biotherapeutics, Inc.?

Yes. Atara Biotherapeutics, Inc. trades publicly on NASDAQ as ATRA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Atara Biotherapeutics, Inc.

Detailed equity research is provided by MarketSnap.